首页> 美国卫生研究院文献>other >Unsupervised detection of cancer driver mutations with parsimony-guided learning
【2h】

Unsupervised detection of cancer driver mutations with parsimony-guided learning

机译:通过简约指导学习无监督地检测癌症驾驶员突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Methods are needed to reliably prioritize biologically active driver mutations over inactive passengers in high-throughput cancer sequencing datasets. We present ParsSNP, an unsupervised functional impact predictor that is guided by parsimony. ParsSNP uses an expectation-maximization framework to find mutations that explain tumor incidence broadly, without using pre-defined training labels that can introduce biases. We compare ParsSNP to five existing tools (CanDrA, CHASM, FATHMM Cancer, TransFIC, Condel) across five distinct benchmarks. ParsSNP outperformed the existing tools in 24 out of 25 comparisons. To investigate the real-world benefit of these improvements, ParsSNP was applied to an independent dataset of thirty patients with diffuse-type gastric cancer. It identified many known and likely driver mutations that other methods did not detect, including truncation mutations in known tumor suppressors and the recurrent driver RHOA Y42C. In conclusion, ParsSNP uses an innovative, parsimony-based approach to prioritize cancer driver mutations and provides dramatic improvements over existing methods.
机译:在高通量癌症测序数据集中,需要有方法来可靠地确定生物活性驾驶员突变的优先级,使其高于非活性乘客的优先级。我们介绍ParsSNP,由简约指导的无监督功能影响预测器。 ParsSNP使用期望最大化框架来查找可广泛解释肿瘤发生率的突变,而无需使用会引入偏差的预定义训练标签。我们将ParsSNP与五个不同基准中的五个现有工具(CanDrA,CHARM,FATHMM Cancer,TransFIC,Condel)进行比较。在25个比较中,有24个ParsSNP优于现有工具。为了研究这些改进的现实益处,将ParsSNP应用于独立的数据集,该数据集包含30位弥漫型胃癌患者。它鉴定出许多其他方法无法检测到的已知的和可能的驱动程序突变,包括已知肿瘤抑制因子的截短突变和复发性驱动程序RHOA Y42C。总之,ParsSNP使用一种基于简约方法的创新方法来确定癌症驱动程序突变的优先级,并比现有方法进行了重大改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号